Group | Treatment | Dose |
1 | VLP vaccine without peptides ‘Qβ(1668)’ | 40 µg per dose |
2 | Short peptide VLP vaccine ‘Qβ(1668)-NeoAGS’
| Total 40 µg per dose 10 µg 10 µg 10 µg 10 µg |
3 | Long peptide VLP vaccine ‘Qβ(1668)-NeoAGL’
| Total 40 µg per dose 10 µg 10 µg 10 µg 10 µg |
VLP, virus-like particle.